(Q48617508)

13 February 2018

title

Effects of isotretinoin on obsessive compulsive symptoms, depression, and anxiety in patients with acne vulgaris. (English)

1 reference

13 February 2018

author name string

Yavuz Yesilova

1

1 reference

13 February 2018

Yasin Bez

2

1 reference

13 February 2018

Mustafa Ari

3

1 reference

13 February 2018

Mehmet Cemal Kaya

4

1 reference

13 February 2018

Gokay Alpak

5

1 reference

13 February 2018

publication date

4 September 2011

1 reference

13 February 2018

Journal of Dermatological Treatment

published in

1 reference

13 February 2018

volume

23

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

268-271

1 reference

13 February 2018

Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

The quality of life in acne: a comparison with general medical conditions using generic questionnaires.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Suicide in dermatological patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Isotretinoin (Accutane) and serious psychiatric adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Retinoid-mediated regulation of mood: possible cellular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Psychosocial correlates of the treatment of photodamaged skin with topical retinoic acid: a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

An analysis of reports of depression and suicide in patients treated with isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Isotretinoin and psychopathology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Psychiatric evaluation of the dermatology patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Psychocutaneous disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

Obsessive-compulsive disorder in a dermatology outpatient clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2011.608782

10.3109/09546634.2011.608782

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

21815780

1 reference

13 February 2018